BENITEC BIOPHARMA INC(NASDAQ:BNTC) stock News

BNTC Latest News, Press Relases and Analysis

All

Press Releases

13 days ago - By: Benitec Biopharma Inc.

Benitec Biopharma Provides Operational Updates

a month ago - By: Zacks Investment Research - Mentions: CTAS BCH LGCY AKO ...

Is Cintas (CTAS) Stock Outpacing Its Business Services Peers This Year?

a month ago - By: Zacks Investment Research - Mentions: BCH LGCY AKO ALGM ...

Is Ardagh Metal Packaging (AMBP) Stock Outpacing Its Industrial Products Peers This Year?

a month ago - By: Zacks Investment Research - Mentions: HMY BCH LGCY AKO ...

Are Basic Materials Stocks Lagging Harmony Gold (HMY) This Year?

a month ago - By: Zacks Investment Research - Mentions: BCH LGCY AKO ROOT ...

Is Root (ROOT) Stock Outpacing Its Finance Peers This Year?

a month ago - By: Zacks Investment Research - Mentions: CNP BCH LGCY AKO ...

Are Utilities Stocks Lagging CenterPoint Energy (CNP) This Year?

a month ago - By: Zacks Investment Research - Mentions: LGCY

Are Auto-Tires-Trucks Stocks Lagging Aisin Seiki (ASEKY) This Year?

a month ago - By: Zacks Investment Research - Mentions: LGCY AKO

Are Consumer Staples Stocks Lagging Ahold (ADRNY) This Year?

a month ago - By: Zacks Investment Research - Mentions: LGCY AKO ALGM KARO

Has Karooooo (KARO) Outpaced Other Computer and Technology Stocks This Year?

a month ago - By: Zacks Investment Research - Mentions: MCK LGCY

Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?

2 months ago - By: Zacks Investment Research

Wall Street Analysts See a 65.98% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High?

2 months ago - By: Zacks Investment Research

Recent Price Trend in Benitec Biopharma (BNTC) is Your Friend, Here's Why

2 months ago - By: Yahoo Finance - Mentions: ASPI PTLO HD RBLX ...

ASP Isotopes Enters into Agreement For Potential Acquisition of Renergen

2 months ago - By: Yahoo Finance - Mentions: CRTO JPM VIK CDNS ...

After surge in diesel futures price, retail prices catch up, benchmark rises

2 months ago - By: Zacks Investment Research

Wall Street Analysts Think Benitec Biopharma (BNTC) Could Surge 83.91%: Read This Before Placing a Bet

2 months ago - By: Zacks Investment Research - Mentions: CON

Are Medical Stocks Lagging Benitec Biopharma (BNTC) This Year?

2 months ago - By: Benitec Biopharma Inc.

Benitec Biopharma Releases Third Quarter 2025 Financial Results

3 months ago - By: Zacks Investment Research - Mentions: CON

Is Benitec Biopharma (BNTC) Stock Outpacing Its Medical Peers This Year?

3 months ago - By: Zacks Investment Research - Mentions: CI COR TARS

Will Declining Medical Customers Affect Cigna's Q1 Earnings?

3 months ago - By: Zacks Investment Research

What Makes Benitec Biopharma (BNTC) a New Buy Stock

4 months ago - By: Benzinga - Mentions: RVSB FDX MU NKE ...

Micron Technology, Nike, FedEx And Other Big Stocks Moving Lower In Friday's Pre-Market Session

4 months ago - By: Benzinga - Mentions: RGC IBO INNV SVRA ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

4 months ago - By: Benitec Biopharma Inc.

Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

5 months ago - By: Benitec Biopharma Inc.

Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update

5 months ago - By: Benitec Biopharma Inc.

Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference

6 months ago - By: Benitec Biopharma Inc.

Benitec Biopharma to Participate in Upcoming Conferences in January and February

8 months ago - By: Benitec Biopharma Inc.

Benitec Biopharma to Participate in Upcoming Investor Conferences in December

8 months ago - By: Benitec Biopharma Inc.

Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update

9 months ago - By: Benitec Biopharma Inc.

Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference

9 months ago - By: Benitec Biopharma Inc.

Benitec Biopharma Announces Updated Investor Webcast Information

9 months ago - By: Benitec Biopharma Inc.

Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society

10 months ago - By: Benitec Biopharma Inc.

Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update

10 months ago - By: Benitec Biopharma Inc.

Benitec Biopharma Announces Late Breaking Oral Abstract Presentation on BB-301 Phase 1b/2a Clinical Study at the 29th Annual Congress of the World Muscle Society

a year ago - By: Benitec Biopharma Inc.

Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for First OPMD Subject Treated with Low-Dose BB-301 in Phase 1b/2a Study

a year ago - By: InvestorPlace

BENITEC BIOPHARMA INC (BNTC) Stock News

BNTC Latest News, Press Relases and Analysis

Benitec Biopharma Provides Operational Updates

Is Cintas (CTAS) Stock Outpacing Its Business Services Peers This Year?

Is Ardagh Metal Packaging (AMBP) Stock Outpacing Its Industrial Products Peers This Year?

Are Basic Materials Stocks Lagging Harmony Gold (HMY) This Year?

Is Root (ROOT) Stock Outpacing Its Finance Peers This Year?

Are Utilities Stocks Lagging CenterPoint Energy (CNP) This Year?

Are Auto-Tires-Trucks Stocks Lagging Aisin Seiki (ASEKY) This Year?

Are Consumer Staples Stocks Lagging Ahold (ADRNY) This Year?

Has Karooooo (KARO) Outpaced Other Computer and Technology Stocks This Year?

Is McKesson (MCK) Stock Outpacing Its Medical Peers This Year?

Wall Street Analysts See a 65.98% Upside in Benitec Biopharma (BNTC): Can the Stock Really Move This High?

Recent Price Trend in Benitec Biopharma (BNTC) is Your Friend, Here's Why

ASP Isotopes Enters into Agreement For Potential Acquisition of Renergen

After surge in diesel futures price, retail prices catch up, benchmark rises

Wall Street Analysts Think Benitec Biopharma (BNTC) Could Surge 83.91%: Read This Before Placing a Bet

Are Medical Stocks Lagging Benitec Biopharma (BNTC) This Year?

Benitec Biopharma Releases Third Quarter 2025 Financial Results

Is Benitec Biopharma (BNTC) Stock Outpacing Its Medical Peers This Year?

Will Declining Medical Customers Affect Cigna's Q1 Earnings?

What Makes Benitec Biopharma (BNTC) a New Buy Stock

Micron Technology, Nike, FedEx And Other Big Stocks Moving Lower In Friday's Pre-Market Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benitec Biopharma Reports Positive Interim Clinical Results for Three Subjects Treated with BB-301 in Phase 1b/2a Study to be Presented at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference

Benitec Biopharma Releases Second Quarter 2025 Financial Results and Provides Operational Update

Benitec Biopharma Announces Acceptance of Late- Breaking Oral Abstract for the BB-301 Phase 1b/2a Clinical Study at the Muscular Dystrophy Association Clinical and Scientific Conference

Benitec Biopharma to Participate in Upcoming Conferences in January and February

Benitec Biopharma to Participate in Upcoming Investor Conferences in December

Benitec Biopharma Releases First Quarter 2025 Financial Results and Provides Operational Update

Benitec Biopharma CEO to Participate in the Guggenheim Securities Healthcare Conference

Benitec Biopharma Announces Updated Investor Webcast Information

Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society

Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update

Benitec Biopharma Announces Late Breaking Oral Abstract Presentation on BB-301 Phase 1b/2a Clinical Study at the 29th Annual Congress of the World Muscle Society

Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for First OPMD Subject Treated with Low-Dose BB-301 in Phase 1b/2a Study

BNTC Stock Earnings: Benitec Biopharma Misses EPS for Q3 2024